TREAT Asia
Program Areas
Adding to HIV Prevention Options in the Asia-Pacific Region
amfAR’s TREAT Asia program has created a guide to lenacapavir for HIV prevention, an injectable form of PrEP.
Meet the TREAT Asia Community Advisory Group
amfAR has enlisted experts and advocates to help guide the program’s research activities across the Asia-Pacific region.
Making Cervical Cancer and HIV in the Asia-Pacific Region a Priority
amfAR TREAT Asia’s program helps accelerate cervical cancer and HIV research to improve the health of women and others at risk in the Asia-Pacific.
The Resilience of the HIV Research Community
Dr. Annette Sohn, amfAR VP and Director of TREAT Asia, shares highlights from CROI 2026—PrEP access efforts, HIV and aging studies, and evidence of the enduring power of science.
Advancing HIV Science in the Asia-Pacific Region
At the 28th Bangkok Symposium, researchers from amfAR’s TREAT Asia program shared advances in HIV science in the Asia-Pacific region, from cervical cancer to an HIV cure and long-acting agents to treat and prevent.